Precision BioSciences Inc (NASDAQ:DTIL)
| 9.58 Delayed Data As of Dec 10 |  +0.08 / +0.84%Today’s Change | 6.24 Today|||52-Week Range 23.67 | -- Year-to-Date |
Latest DTIL News | Press Releases
| Why International Flavors & Fragrances, Precision BioSciences, and GameStop Slumped Today Dec 09 / MotleyFool.com - Paid Partner Content | Here's Why Shares of This Gene Editing Pioneer Are Collapsing Today Dec 09 / MotleyFool.com - Paid Partner Content |
| No CRISPR Required: This Forgotten Gene Editing is Up 50% in 5 Weeks Dec 09 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 9.50 |
| Today’s open | 10.13 |
| Day’s range | 9.51 - 10.50 |
| Volume | 3,631,854 |
| Average volume (3 months) | 576,876 |
| Market cap | $996.9M |
Data as of 4:00pm ET, 12/10/2019
Growth & Valuation
| Earnings growth (last year) | -118.18% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +67.84% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 24.67 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MRUSMerus NV | +0.54 | +3.30% |
| MORFMorphic Holding Inc | +0.10 | +0.61% |
| REPLReplimune Group Inc | -0.40 | -2.84% |
| MGTAMagenta Therapeutics... | +1.21 | +9.46% |
Data as of 4:00pm ET, 12/10/2019
Financials
| Next reporting date | February 26, 2020 |
| EPS forecast (this quarter) | -$0.47 |
| Annual revenue (last year) | $10.9M |
| Annual profit (last year) | -$46.0M |
| Net profit margin | -423.02% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Durham, North Carolina |
Forecasts
